Characteristics | Treatment outcome | P- value | Crude Odds Ratio (COR)(95%CI) | |
---|---|---|---|---|
Successful Treatment | Unsuccessful Treatment | |||
Sex | ||||
 Male | 141 (87.6%) | 20 (12.4%) | 0.699 | 1.00 |
 Female | 162 (86.2%) | 26 (13.8%) | 0.88 (0.44–1.57) | |
Age group | ||||
 1–15 years | 9 (90.0%) | 1 (10.0%) | 0.741 | 1.43 (0.17–11.89) |
 16–30 years | 126 (86.3%) | 20 (13.7%) |  | 1.00 |
 31–45 years | 122 (89.1%) | 15 (10.9%) | 0.483 | 1.29 (0.63–2.64) |
  > 45 years | 46 (82.1%) | 10 (17.9%) | 0.458 | 0.73 (0.32–1.68) |
Place of residence | ||||
 Urban | 249 (87.7%) | 35 (12.3%) | 0.325 | 1.00 |
 Rural | 54 (83.1%) | 11 (16.9%) | 0.69 (0.33–1.44) | |
Pretreatment weight | ||||
 20–29 Kg | 4 (80.0%) | 1 (20.0%) | 0.529 | 0.49 (0.05–4.59) |
 30–39 Kg | 16 (72.7%) | 6 (27.3%) | 0.037 | 0.32 (0.11–0.93) |
 40–54 Kg | 135 (86.5%) | 21 (13.5%) | 0.473 | 0.78 (0.40–1.53) |
  > 54 Kg | 148 (89.2%) | 18 (10.8%) |  | 1.00 |
Pretreatment BMI (kg/m2) | ||||
  < 18.5 | 81 (82.7%) | 17 (17.3%) |  | 1.00 |
 18.5–24.9 | 176 (87.6%) | 25 (12.4%) | 0.251 | 1.48 (0.76–2.89) |
  ≥ 25 | 46 (92.0%) | 4 (8.0%) | 0.132 | 2.41 (0.77–7.61) |
Year of TB treatment initiated | ||||
 2012 | 36 (87.8%) | 5 (12.2%) |  | 1.00 |
 2013 | 61 (88.4%) | 8 (11.6%) | 0.925 | 1.06 (0.32–3.48) |
 2014 | 60 (85.7%) | 10 (14.3%) | 0.756 | 0.83 (0.26–2.63) |
 2015 | 62 (87.3%) | 9 (12.7%) | 0.941 | 0.96 (0.30–3.08) |
 2016 | 57 (89.1%) | 7 (10.9%) | 0.843 | 1.13 (0.33–3.84) |
 2017 | 27 (79.4%) | 7 (20.6%) | 0.328 | 0.54 (0.15–1.87) |